SYNDAX PHARMACEUTICALS INC
SNDX·87164F105·US·Common Stock·Healthcare - Biotechnology-13D/G
SNDX (SYNDAX PHARMACEUTICALS INC) is held by 134 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($197.2M), GOLDMAN SACHS GROUP INC ($128.1M), STATE STREET CORP ($123.7M). Net institutional sentiment: Mixed.
134
Holders
(10 Elite)
$1.5B
Total Value
53% (139)
Consensus
73 buying - 66 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders Jul 9, 2026 · Activists Aug 7, 2026 · Congress none
InsiderMAMetzger Michael ASell $785KJul 8, 2026
InsiderMAMetzger Michael AExercise 32K shJul 8, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 149
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer